glecaprevir 100 MG / pibrentasvir 40 MG Oral Tablet

RxCUI: 1940703
RxNorm name: glecaprevir 100 MG / pibrentasvir 40 MG Oral Tablet
Display name: glecaprevir 100 MG / pibrentasvir 40 MG Oral Tablet
Full name: glecaprevir 100 MG / pibrentasvir 40 MG Oral Tablet
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:05

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Mavyret	GLECAPREVIR AND PIBRENTASVIR	AbbVie Inc.	7bf99777-0401-9095-8645-16c6e907fcc0	2025-06-25	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1940703

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
7bf99777-0401-9095-8645-16c6e907fcc0	glecaprevir 100 MG / pibrentasvir 40 MG Oral Tablet	PSN	200	These highlights do not include all the information needed to use MAVYRET safely and effectively. See full prescribing information for MAVYRET. MAVYRET ® (glecaprevir and pibr entasvir) tablets, for oral use MAVYRET ® (glecaprevir and pibrentasvir) oral pellets Initial U.S. Approval: 2017	20250610
7bf99777-0401-9095-8645-16c6e907fcc0	glecaprevir 100 MG / pibrentasvir 40 MG Oral Tablet	SCD	200	These highlights do not include all the information needed to use MAVYRET safely and effectively. See full prescribing information for MAVYRET. MAVYRET ® (glecaprevir and pibr entasvir) tablets, for oral use MAVYRET ® (glecaprevir and pibrentasvir) oral pellets Initial U.S. Approval: 2017	20250610